Goodwin

Partner

Caroline Bullerjahn, a partner in Goodwin’s Securities Litigation & White Collar Defense practice and a leader of the firm’s Life Sciences Disputes group, focuses her securities litigation practice on class action and derivative litigation defense, SEC, and other government, regulatory and internal investigations, fiduciary duty claims, corporate governance matters, and shareholder disputes, M&A-related litigation and post-closing disputes, and SPAC litigation. She is a member of the firm’s Partnership Committee.

Ms. Bullerjahn is recognized by The Legal 500 U.S. for her securities litigation practice, and has been recognized as a Massachusetts Super Lawyer “Rising Star” for her representation of both private and publicly traded corporations, primarily in the life sciences, biotechnology, medical device, healthcare and technology industries, and their officers and directors in such securities litigation matters. In addition, she advises clients and their boards of directors on disclosure-related issues and litigation risk mitigation measures.

J.D., 2003 Northwestern University / B.A., 1998 University of Pennsylvania (magna cum laude)